NeuroMetrix Company Profile (NASDAQ:NURO)

About NeuroMetrix (NASDAQ:NURO)

NeuroMetrix logoNeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NURO
  • CUSIP: N/A
  • Web: www.neurometrix.com
Capitalization:
  • Market Cap: $3.66 million
  • Outstanding Shares: 2,126,000
Average Prices:
  • 50 Day Moving Avg: $1.96
  • 200 Day Moving Avg: $1.87
  • 52 Week Range: $0.38 - $4.50
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.22
  • P/E Growth: -0.01
Sales & Book Value:
  • Annual Revenue: $15.72 million
  • Price / Sales: 0.27
  • Book Value: $2.83 per share
  • Price / Book: 0.70
Profitability:
  • EBIDTA: ($13,270,000.00)
  • Net Margins: -83.92%
  • Return on Equity: -209.56%
  • Return on Assets: -135.03%
Debt:
  • Current Ratio: 2.13%
  • Quick Ratio: 1.73%
Misc:
  • Average Volume: 47,958 shs.
  • Beta: 0.38
  • Short Ratio: 1.7
 

Frequently Asked Questions for NeuroMetrix (NASDAQ:NURO)

What is NeuroMetrix's stock symbol?

NeuroMetrix trades on the NASDAQ under the ticker symbol "NURO."

When did NeuroMetrix's stock split? How did NeuroMetrix's stock split work?

NeuroMetrix's stock reverse split on the morning of Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. An investor that had 100 shares of NeuroMetrix stock prior to the reverse split would have 13 shares after the split.

How were NeuroMetrix's earnings last quarter?

NeuroMetrix, Inc. (NASDAQ:NURO) posted its quarterly earnings data on Thursday, July, 20th. The company reported ($2.49) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($2.83) by $0.34. The business earned $4.31 million during the quarter, compared to analysts' expectations of $4.40 million. NeuroMetrix had a negative return on equity of 209.56% and a negative net margin of 83.92%. View NeuroMetrix's Earnings History.

When will NeuroMetrix make its next earnings announcement?

NeuroMetrix is scheduled to release their next quarterly earnings announcement on Wednesday, October, 18th 2017. View Earnings Estimates for NeuroMetrix.

Where is NeuroMetrix's stock going? Where will NeuroMetrix's stock price be in 2017?

2 brokers have issued 12-month price targets for NeuroMetrix's shares. Their predictions range from $16.00 to $36.00. On average, they anticipate NeuroMetrix's share price to reach $26.00 in the next year. View Analyst Ratings for NeuroMetrix.

Who are some of NeuroMetrix's key competitors?

Who are NeuroMetrix's key executives?

NeuroMetrix's management team includes the folowing people:

  • Shai N. Gozani M.D., Ph.D., Chairman of the Board, President, Chief Executive Officer, Secretary
  • Thomas T. Higgins, Chief Financial Officer, Senior Vice President, Treasurer
  • Francis X. McGillin, Senior Vice President, General Manager - Consumer Wearables
  • David E. Goodman M.D., Independent Director
  • Allen J. Hinkle M.D., Independent Director
  • Nancy E. Katz, Independent Director
  • Timothy R. Surgenor, Independent Director
  • David Van Avermaete, Independent Director

How do I buy NeuroMetrix stock?

Shares of NeuroMetrix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NeuroMetrix's stock price today?

One share of NeuroMetrix stock can currently be purchased for approximately $1.97.


MarketBeat Community Rating for NeuroMetrix (NASDAQ NURO)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  66 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  123
MarketBeat's community ratings are surveys of what our community members think about NeuroMetrix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for NeuroMetrix (NASDAQ:NURO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.00 (1,219.80% upside)

Analysts' Ratings History for NeuroMetrix (NASDAQ:NURO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/15/2017HC WainwrightSet Price TargetBuy$16.00LowView Rating Details
10/21/2016Rodman & RenshawReiterated RatingBuy$36.00N/AView Rating Details
2/29/2016Dawson JamesReiterated RatingBuyN/AView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for NeuroMetrix (NASDAQ:NURO)
Earnings by Quarter for NeuroMetrix (NASDAQ:NURO)
Earnings History by Quarter for NeuroMetrix (NASDAQ NURO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/18/2017N/AView Earnings Details
7/20/2017Q2 2017($2.83)($2.49)$4.40 million$4.31 millionViewN/AView Earnings Details
4/20/2017Q1 2017($3.92)($7.28)$4.17 million$4.31 millionViewN/AView Earnings Details
1/26/2017Q416($6.00)($4.16)$3.48 million$3.70 millionViewListenView Earnings Details
10/20/2016Q316($6.56)($6.08)$3.01 million$3.39 millionViewListenView Earnings Details
7/21/2016Q216($7.44)($42.96)$1.22 million$2.65 millionViewListenView Earnings Details
4/21/2016Q116($7.60)($8.00)$2.65 million$2.28 millionViewListenView Earnings Details
10/22/2015Q315($0.64)($2.08)$6.47 million$2.10 millionViewListenView Earnings Details
7/22/2015Q215($3.84)$9.80 million$1.22 millionViewListenView Earnings Details
2/12/2015Q414($2.88)$4.62 million$1.41 millionViewN/AView Earnings Details
7/24/2014Q413($6.80)$1.16 million$1.34 millionViewN/AView Earnings Details
2/13/2014($6.96)ViewListenView Earnings Details
10/23/2013Q313($2.08)$1.77 million$1.31 millionViewListenView Earnings Details
7/25/2013Q2 2013($7.36)$2.20 million$1.20 millionViewN/AView Earnings Details
2/3/2011($1.36)($1.44)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NeuroMetrix (NASDAQ:NURO)
Current Year EPS Consensus Estimate: $-11.20 EPS
Next Year EPS Consensus Estimate: $-1.62 EPS

Dividends

Dividend History for NeuroMetrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for NeuroMetrix (NASDAQ:NURO)
Insider Ownership Percentage: 4.40%
Institutional Ownership Percentage: 6.53%
Insider Trades by Quarter for NeuroMetrix (NASDAQ:NURO)
Institutional Ownership by Quarter for NeuroMetrix (NASDAQ:NURO)
Insider Trades by Quarter for NeuroMetrix (NASDAQ:NURO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2017Thomas T HigginsInsiderBuy1,000$2.83$2,830.00View SEC Filing  
6/16/2017Shai GozaniCEOBuy3,500$2.90$10,150.00View SEC Filing  
6/15/2017Thomas T HigginsInsiderBuy3,500$2.98$10,430.00View SEC Filing  
6/14/2017Shai GozaniCEOBuy5,000$2.97$14,850.00View SEC Filing  
6/14/2017Thomas T HigginsInsiderBuy2,300$2.97$6,831.00View SEC Filing  
11/1/2016Shai GozaniCEOBuy3,000$1.31$3,930.00View SEC Filing  
10/28/2016Thomas T HigginsInsiderBuy3,000$1.32$3,960.00View SEC Filing  
10/27/2016Shai GozaniCEOBuy6,000$1.32$7,920.00View SEC Filing  
8/31/2016Thomas T HigginsCFOBuy1,400$1.41$1,974.00View SEC Filing  
8/18/2016Shai GozaniCEOBuy5,000$1.49$7,450.00View SEC Filing  
8/12/2016Thomas T HigginsInsiderBuy2,000$1.45$2,900.00View SEC Filing  
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for NeuroMetrix (NASDAQ:NURO)
Latest Headlines for NeuroMetrix (NASDAQ:NURO)
Source:
DateHeadline
americanbankingnews.com logoHead to Head Contrast: Tandem Diabetes Care (TNDM) versus NeuroMetrix (NURO)
www.americanbankingnews.com - September 19 at 12:56 PM
finance.yahoo.com logoBefore You Buy NeuroMetrix Inc’s (NURO), You Should Consider This
finance.yahoo.com - September 19 at 5:44 AM
seekingalpha.com logoNeuroMetrix (NURO) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 12 at 7:16 AM
americanbankingnews.com logoComparing Asante Solutions (PUMP) & NeuroMetrix (NURO)
www.americanbankingnews.com - September 9 at 6:44 PM
americanbankingnews.com logoSyneron Medical (ELOS) vs. NeuroMetrix (NURO) Financial Analysis
www.americanbankingnews.com - September 8 at 10:28 PM
finance.yahoo.com logoNeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12th, 2017
finance.yahoo.com - September 6 at 7:02 AM
finance.yahoo.com logoTwo Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference
finance.yahoo.com - September 1 at 6:31 AM
finance.yahoo.com logoNeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain
finance.yahoo.com - August 30 at 7:25 AM
americanbankingnews.com logoComparing Asante Solutions (PUMP) and NeuroMetrix (NURO)
www.americanbankingnews.com - August 17 at 4:50 AM
finance.yahoo.com logoNeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep
finance.yahoo.com - August 15 at 4:32 PM
finance.yahoo.com logoNeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan
finance.yahoo.com - August 4 at 6:27 AM
businesswire.com logoNeuroMetrix Announces Shipment of 100000 - Business Wire (press release)
www.businesswire.com - July 29 at 5:41 AM
finance.yahoo.com logoNeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015
finance.yahoo.com - July 28 at 6:18 AM
finance.yahoo.com logoNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q2, 2017 By the Numbers : July 24, 2017
finance.yahoo.com - July 25 at 6:19 AM
businesswire.com logoNeuroMetrix Reports Q2 2017 Financial Results - Business Wire (press release)
www.businesswire.com - July 22 at 7:05 AM
americanbankingnews.com logoNeuroMetrix, Inc. (NURO) Announces Earnings Results
www.americanbankingnews.com - July 21 at 11:05 AM
finance.yahoo.com logoInvestor Network: NeuroMetrix, Inc. to Host Earnings Call
finance.yahoo.com - July 21 at 4:30 AM
finance.yahoo.com logoNeuroMetrix Reports Q2 2017 Financial Results
finance.yahoo.com - July 21 at 4:30 AM
finance.yahoo.com logoEdited Transcript of NURO earnings conference call or presentation 20-Jul-17 12:00pm GMT
finance.yahoo.com - July 21 at 4:30 AM
businesswire.com logoNeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call - Business Wire (press release)
www.businesswire.com - July 13 at 7:27 AM
finance.yahoo.com logoNeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call
finance.yahoo.com - July 13 at 7:27 AM
seekingalpha.com logoNeuroMetrix, Inc. (NURO)
seekingalpha.com - July 12 at 6:30 AM
finance.yahoo.com logoNeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock
finance.yahoo.com - July 11 at 6:04 AM
finance.yahoo.com logoNeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics
finance.yahoo.com - July 6 at 7:35 AM
americanbankingnews.com logoZacks Investment Research Upgrades NeuroMetrix, Inc. (NASDAQ:NURO) to Buy
www.americanbankingnews.com - July 5 at 7:32 AM
businesswire.com logoNeuroMetrix Provides Update on Quell Health Cloud Including ... - Business Wire (press release)
www.businesswire.com - June 27 at 6:49 AM
finance.yahoo.com logoNeuroMetrix Provides Update on Quell Health Cloud Including Promotion of Dr. Xuan Kong to Chief Data Scientist
finance.yahoo.com - June 27 at 6:49 AM
finance.yahoo.com logoNeuroMetrix Provides Update on Quell Wearable Pain Relief Clinical Program
finance.yahoo.com - June 23 at 7:30 PM
americanbankingnews.com logoInsider Buying: NeuroMetrix, Inc. (NURO) CEO Acquires 3,500 Shares of Stock
www.americanbankingnews.com - June 16 at 4:50 PM
americanbankingnews.com logoHC Wainwright Analysts Give NeuroMetrix, Inc. (NURO) a $16.00 Price Target
www.americanbankingnews.com - June 16 at 1:16 AM
americanbankingnews.com logoInsider Buying: NeuroMetrix, Inc. (NURO) Insider Acquires 3,500 Shares of Stock
www.americanbankingnews.com - June 15 at 8:08 PM
americanbankingnews.com logoNeuroMetrix, Inc. (NURO) CEO Acquires $14,850.00 in Stock
www.americanbankingnews.com - June 14 at 4:28 PM
finance.yahoo.com logoToday's Research Reports on Stocks to Watch: Cleantech Solutions and NeuroMetrix
finance.yahoo.com - June 14 at 9:14 AM
seekingalpha.com logoNeuroMetrix (NURO) Presents At 7th Annual LD Micro Invitational Conference - Slideshow
seekingalpha.com - June 9 at 7:07 PM
finance.yahoo.com logoNeuroMetrix to Present at the Marcum Microcap Conference on June 16, 2017
finance.yahoo.com - June 8 at 9:45 AM
finance.yahoo.com logoNeuroMetrix Exhibits Quell Wearable Technology at 31st Annual SLEEP Meeting
finance.yahoo.com - June 6 at 7:39 PM
americanbankingnews.com logoNeurometrix Inc (NURO) Downgraded to Strong Sell at ValuEngine
www.americanbankingnews.com - June 3 at 11:58 PM
finance.yahoo.com logoNeuroMetrix to Present at the LD Micro Invitational Conference on June 6, 2017
finance.yahoo.com - May 30 at 9:04 AM
finance.yahoo.com logoNeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology
finance.yahoo.com - May 22 at 6:10 PM
americanbankingnews.com logoNeurometrix Inc (NURO) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - May 18 at 2:50 PM
finance.yahoo.com logoNeuroMetrix Wins SBANE New England Innovation Award
finance.yahoo.com - May 17 at 6:52 PM
streetinsider.com logoNeuroMetrix (NURO) Says Preliminary Results from Study Evaluating Quell in Chemotherapy-Induced Peripheral Neuropathy to be Presented at APS Meeting
www.streetinsider.com - May 16 at 10:10 AM
finance.yahoo.com logoNeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain
finance.yahoo.com - May 16 at 10:10 AM
finance.yahoo.com logoPreliminary Results from Clinical Study Evaluating Use of Quell in Chemotherapy-Induced Peripheral Neuropathy to be presented at the American Pain Society Annual Meeting
finance.yahoo.com - May 15 at 6:14 PM
streetinsider.com logoNeuroMetrix (NURO) Declares 1-for-8 Reverse Stock Split
www.streetinsider.com - May 13 at 8:20 AM
finance.yahoo.com logoNeuroMetrix Announces One-for-Eight Reverse Split
finance.yahoo.com - May 11 at 7:24 PM
streetinsider.com logoNeuroMetrix (NURO) Announces Expansion of International Intellectual Property Assets for Quell
www.streetinsider.com - May 8 at 6:24 PM
businesswire.com logoNeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology
www.businesswire.com - May 8 at 12:15 PM
finance.yahoo.com logoNeuroMetrix Hosts Inaugural Quell User Event
finance.yahoo.com - May 5 at 7:11 PM
americanbankingnews.com logoNeurometrix (NURO) Getting Somewhat Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - May 3 at 3:24 PM

Social

Chart

NeuroMetrix (NURO) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff